Posted on November 25, 2009 by svigneault
Loftware is pleased to announce, as an extension of our blog, a series of educational webinars to focus on the process of meeting unique device identification requirements and the adoption of GS1 data standards.
Our kick-off session will be held on December 1, 2009 and registration can be found here.
This first session will focus on the [...]
Filed under: FDA related, GS1, GS1 Adoption, Global Standards | Tagged: label consolidation | Leave a Comment »
Posted on November 11, 2009 by sterling1
This news comes from Healthcare Purchasing News: VHA Inc. and 13 of its largest health system members have sent a letter to the U.S. Food & Drug Administration requesting prompt issuance of Unique Device Identification (UDI) regulations, and that those regulations include GS1 supply chain standards. At this link, you can see the full release direct [...]
Filed under: Bar code, C-Level Issues, FDA related, GS1, GS1 Adoption, Hospital, supply chain | Leave a Comment »
Posted on November 5, 2009 by Christopher Little
I go to the U.S. Food and Drug Administration (FDA) website almost every day to glimpse their recent news releases. That’s because sometimes their announcements don’t seem to get much pick up in the usual places. Yesterday they issued this news release. The headline is: FDA Unveils Safe Use Initiative that Targets Preventable Harm from Medication [...]
Filed under: C-Level Issues, FDA related, GS1, Miscellaneous, Patient safety, Pharma | Leave a Comment »
Posted on October 23, 2009 by Christopher Little
GS1 has alerted us to the availability of online videos and presentations captured in Hong Kong in early October during the GS1 Healthcare Conference.
Filed under: FDA related, GS1 | Leave a Comment »
Posted on October 20, 2009 by sterling1
This is a reminder of the UDI 2009 Conference that gets underway twelve hours from now, in Orlando. Take a look at this event site and tell me it doesn’t have ‘decision-time’ written all over it.
Filed under: FDA related, GS1 | Leave a Comment »
Posted on October 19, 2009 by Christopher Little
“The Upside of a Unique Device Identification (UDI) Mandate” is the topic of an online keynote speech that will be given by Jay Crowley, senior advisor for patient safety, Center for Devices and Radiological Health, of the U.S. Food and Drug Administration (FDA) on December 2 as part of the Track & Trace Virtual Trade Show.
Filed under: FDA related, GS1, Patient safety, Track & Trace | Leave a Comment »
Posted on October 15, 2009 by Christopher Little
In this article, entitled “Major pharmaceutical companies see generics as a bridge to the future,” writer Clay Boswell first provides a review of all the major acquisitions, mergers and joint marketing agreements by large pharmaceutical companies over the past couple of years.
Filed under: Emerging Markets Labeling, FDA related, GS1, Global Standards, Miscellaneous, Pharma | Leave a Comment »
Posted on October 6, 2009 by Christopher Little
The Associated Press put out a story today that’s getting a lot of traction and that’s good because this report, entitled “US has no good system to track medical implants” is bound to get a lot of average people interested very quickly in what needs to happen. It also might get a lot of the [...]
Filed under: FDA related, GS1, Patient safety, Track & Trace | Leave a Comment »
Posted on October 2, 2009 by Christopher Little
By now you’re aware of the upcoming Oracle OpenWorld event starting
Filed under: FDA related, GS1, Miscellaneous | Leave a Comment »
Posted on September 30, 2009 by Christopher Little
Here’s a look at an email we got from GS1 Healthcare US about the upcoming UDI Conference being held October 20-21, 2009, in Orlando, Florida. It says attendees can expect to receive first-hand information on the progress and direction of the Food and Drug Administration’s (FDA) Unique Device Identification (UDI) draft regulation at this [...]
Filed under: FDA related, GS1, GS1 Adoption, Global Standards | 1 Comment »
Posted on September 29, 2009 by Christopher Little
Big news: In an email today from John Roberts, Director, GS1 Healthcare US, we’re being informed that at a recent seminar in China conducted by AdvaMed, which is a major association of advanced medical technology producers, officials representing the China State Food and Drug Administration (SFDA) said they plan to follow the
Filed under: C-Level Issues, FDA related, GS1, GS1 Adoption, Track & Trace | Leave a Comment »
Posted on September 29, 2009 by Christopher Little
In an online story from the UK’s Financial Times, writer Marko Dimitrijevic says this: The term emerging markets is obsolete. They represent half of the world’s economy; their financial markets are large and liquid, with volatility, corporate governance and government policies very similar to those of developed markets. The traditional distinctions between emerging and developed markets, once [...]
Filed under: C-Level Issues, Emerging Markets Labeling, FDA related, GS1 | Leave a Comment »
Posted on September 22, 2009 by Christopher Little
Editor’s note: As an editorial decision since the inception of this blog, I’ve steered away from Loftware promotional posts. The panel session cited above, in my opinion, is news and the fact Loftware is in the middle of it, well, does it lose its news worthiness and become an ad? No, I don’t think so.
Announced [...]
Filed under: C-Level Issues, FDA related, GS1, GS1 Adoption, Global Standards, Miscellaneous | 2 Comments »
Posted on September 15, 2009 by sterling1
I should have caught this in July when FDA NEWS posted this update from Jay Crowley, who is the Food and Drug Administration’s senior adviser for patient safety:
Filed under: FDA related, GS1 | 1 Comment »
Posted on September 9, 2009 by svigneault
The Food and Drug Administration on Tuesday unveiled a new electronic database where manufacturers must notify the government if they believe one of their products is likely to cause sickness or death in people or animals.
Filed under: FDA related, GS1, Patient safety | Leave a Comment »
Posted on September 4, 2009 by Christopher Little
The US Food and Drug Administration (FDA) plans to make electronic filing of safety reports mandatory by this time next year according to this news report in Government Health IT. It is a change the FDA says will help it detect emerging safety problems sooner and respond with safety information to the public in less [...]
Filed under: FDA related, Patient safety | Leave a Comment »
Posted on September 2, 2009 by Christopher Little
This is the first of several planned posts about a major healthcare technology panel at Oracle OpenWorld 2009 in San Francisco (where Loftware will also be exhibiting in booth 3108, West Exhibition Hall). While Oracle’s chief focus this year at the October show is rightfully on their formal launch yesterday of 11g Release 2 of its database, [...]
Filed under: C-Level Issues, FDA related, GS1, Global Standards | Leave a Comment »
Posted on August 13, 2009 by sterling1
Medical device manufacturers are already facing some uncertainty about impending rules for device identification. Now, they also face a new regulator.
Filed under: FDA related | Leave a Comment »
Posted on August 11, 2009 by Christopher Little
Some days I am very optimistic about the changes afoot to make the Food and Drug Administration a stronger, more powerful place. New
Filed under: C-Level Issues, FDA related, GS1, Patient safety | Leave a Comment »
Posted on August 4, 2009 by sterling1
File this under, ‘It’s about time!” The US House of Representatives has passed a bill that will require more food safety measures. It will give more power to the FDA in demanding recalls and creating a better product tracing
Filed under: FDA related, GS1, Patient safety, Track & Trace | Leave a Comment »